Tumor-suppressor activity of RRIG1 in breast cancer

Riferimento: 
BMC Cancer. 2011 Jan 25;11:32.
Autori: 
Zhang G, Brewster A, Guan B, Fan Z, Brown PH, Xu XC.
Fonte: 
BMC Cancer. 2011 Jan 25;11:32.
Anno: 
2011
Azione: 
… l'espressione del recettore dei retinoidi del gene-1 (RRIG1) ha inibito la proliferazione, la formazione di colonie, la migrazione e l'invasione delle cellule nel cancro al seno.
Target: 
RRIG1/carcinoma mammario.

BACKGROUND:
Retinoid receptor-induced gene-1 (RRIG1) is a novel gene that has been lost in several types of human cancers. The aim of this study was to determine whether RRIG1 plays a role in breast cancer, such as in the suppression of breast cancer cell growth and invasion.
METHODS:
Immunohistochemistry was used to detect RRIG1 expression in breast tissue specimens. Gene transfection was used to restore or knock down RRIG1 expression in breast cancer cell lines for analysis of cell viability, colony formation, and migration/invasion potential. Reverse- transcription polymerase chain reaction and western blot assays were used to detect the changes in gene expression. The RhoA activation assay was used to assess RRIG1-induced inhibition of RhoA activity.
RESULTS:
The immunohistochemical data showed that RRIG1 expression was reduced in breast cancer tissues compared with normal and atypical hyperplastic breast tissues. RRIG1 expression was inversely correlated with lymph node metastasis of breast cancer but was not associated with the status of hormone receptors, such as estrogen receptor, progesterone receptor, or HER2. Furthermore, restoration of RRIG1 expression inhibited proliferation, colony formation, migration, and invasion of breast cancer cells. Expression of RRIG1 also reduced phosphorylated Erk1/2 and Akt levels; c-Jun, MMP9, and Akt expressions; and RhoA activity. In contrast, knockdown of RRIG1 expression promoted breast cancer cell proliferation, colony formation, migration, and invasion potential.
CONCLUSION:
The data from the current study indicated that RRIG1 expression was reduced or lost in breast cancer and that restoration of RRIG1 expression suppressed breast cancer cell growth and invasion capacity. Future studies will determine the underlying molecular mechanisms and define RRIG1 as a tumor-suppressor gene in breast cancer.

Sostanze: